Cannara Biotech Inc. (LOVFF)

Cannara Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is September - August.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 8, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020
Market Capitalization	87	45	67	91	118	54
Market Cap Growth	33.35%	-32.08%	-26.24%	-23.18%	119.59%	-34.84%
Enterprise Value	118	78	97	112	127	57
Last Close Price	0.93	0.54	0.75	1.00	1.30	0.75
PE Ratio	9.33	9.51	13.02	51.35	-	-
PS Ratio	1.33	0.75	1.58	3.30	8.75	27.48
PB Ratio	1.33	0.70	1.13	1.77	2.32	1.83
P/TBV Ratio	1.33	0.70	1.13	1.77	2.32	1.84
P/FCF Ratio	27.56	19.05	-	-	-	-
P/OCF Ratio	11.57	5.73	15.29	-	-	-
EV/Sales Ratio	1.75	1.28	2.29	4.07	9.40	29.09
EV/EBITDA Ratio	7.29	7.62	7.92	16.91	58.11	-
EV/EBIT Ratio	10.21	13.69	11.17	30.25	3041.19	-
EV/FCF Ratio	37.56	32.55	-	-	-	-
Debt / Equity Ratio	0.52	0.55	0.57	0.73	0.33	0.34
Debt / EBITDA Ratio	2.16	3.45	2.75	5.54	7.15	-
Debt / FCF Ratio	10.78	15.04	-	-	-	-
Asset Turnover	0.61	0.55	0.43	0.33	0.23	0.04
Inventory Turnover	1.33	1.41	1.14	1.40	1.39	1.09
Quick Ratio	0.64	0.73	0.70	1.75	1.63	2.32
Current Ratio	2.35	2.50	2.44	3.46	2.82	3.03
Return on Equity (ROE)	15.44%	7.68%	9.48%	3.52%	-2.98%	-29.66%
Return on Assets (ROA)	6.55%	3.23%	5.48%	2.77%	0.04%	-12.16%
Return on Capital (ROIC)	7.41%	3.65%	6.09%	3.01%	0.05%	-13.06%
Return on Capital Employed (ROCE)	12.40%	6.00%	9.70%	4.20%	0.10%	-
Earnings Yield	10.72%	10.52%	7.68%	1.95%	-1.03%	-17.81%
FCF Yield	3.63%	5.25%	-4.39%	-18.20%	-22.26%	-26.41%
Buyback Yield / Dilution	-1.66%	-1.83%	-2.16%	-14.80%	-7.26%	-16.02%

Updated Jan 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.